Hormonal maintenance therapy may improve survival in women with chemo-resistant rare ovarian or peritoneum cancer

For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone maintenance therapy (HMT) may significantly improve survival, according to a new study.

from Top Health News – ScienceDaily http://ift.tt/2l8hgmc
from Tumblr http://ift.tt/2lvq32i